Home/Filings/4/0001799191-23-000008
4//SEC Filing

Shah Mihir 4

Accession 0001799191-23-000008

CIK 0001799191other

Filed

May 23, 8:00 PM ET

Accepted

May 24, 8:43 PM ET

Size

6.7 KB

Accession

0001799191-23-000008

Insider Transaction Report

Form 4
Period: 2023-05-23
Shah Mihir
Chief Financial Officer
Transactions
  • Disposition to Issuer

    Common Stock

    2023-05-23$0.43/sh869$372223,472 total
  • Disposition to Issuer

    Common Stock

    2023-05-23$0.43/sh2,573$1,101224,341 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
  • [F2]Price is the volume weighted average selling price of all sales by the Reporting Person on May 23, 2023 within a one-dollar range. Actual prices ranged from $0.4201 to $0.4600. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Issuer

Oncology Institute, Inc.

CIK 0001799191

Entity typeother

Related Parties

1
  • filerCIK 0001676960

Filing Metadata

Form type
4
Filed
May 23, 8:00 PM ET
Accepted
May 24, 8:43 PM ET
Size
6.7 KB